North America Cold Sore Treatment (for HSV 1 Virus) Market

Published May 01, 2024

Length 179 Pages

SKU # DAABD18921318

Description

North America Cold Sore Treatment (for HSV 1 Virus) Market

North America cold sore treatment (for HSV 1 virus) market is expected to reach USD 758.29 million by 2031, from USD 444.91 million in 2023 growing at the CAGR of 7.2% in the forecast period of 2024 to 2031.
Market Segmentation
North America Cold Sore Treatment (for HSV 1 Virus) Market, By Treatment Type (Medications, Applied Products, Cold Sore Patches, and Others(Non Medicated Products)), Route Of Administration (Oral, Topical, and Others), Mode Of Purchase (Over The Counter and Prescription Drug), Strain Type (Herpes Simplex Type 1 Virus and Herpes Simplex Type 2 Virus), Drug Type (Generic and Branded), Population Type (Adults, Pediatrics, and Geriatrics), Gender (Female and Male), End User (Home Healthcare, Hospitals, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others), By Country (U.S., Canada, and Mexico) – Industry Trends and Forecast to 2031
Overview of North America Cold Sore Treatment (for HSV 1 Virus) Market Dynamics
Drivers
• Growing prevalence of cold sore infection
• Growing awareness about cold sore symptoms and treatment options
• Impact of generic drugs on the global cold sore treatment (for HSV 1 virus) market
Restraints
• Development of drug-resistant strains of HSV-1 and H11 viruses
• Lack of curative treatment for infection
Opportunities
• Rising advancements in treatments for cold sore infections
• Increasing adoption of telemedicine and digital health solutions
Challenges
• Increasing complexity of vaccine development
Side effects associated with medications in treating cold sore
Market Players
The key market players for North America cold sore treatment (for HSV 1 virus) market are listed below:
• Fresenius SE & Co. KGaA
• Zydus Pharmaceuticals, Inc.
• Teva Pharmaceuticals Industries Ltd.
• Novartis AG
• Sun Pharmaceutical Industries Ltd.
• Quantum Health
• GSK plc.
• Haleon Group of Companies
• Church & Dwight Co., Inc.
• Hikma Pharmaceuticals PLC
• Viatris Inc.
• Carma Labs Inc.
• URGO MEDICAL
• Apotex Inc.
• Amneal Pharmaceuticals LLC
• Blistex Inc.
• FOCUS CONSUMER HEALTHCARE
• Hetero Healthcare Limited
• Amparo medical Technologies
• Devirex AG

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America Cold Sore Treatment (For Hsv 1 Virus) Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Market Application Coverage Grid; 2.8 Product Lifeline Curve; 2.9 Dbmr Market Position Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’s Five Forces
5 North America Cold Sore Treatment (For Hsv 1 Virus) Market: Regulations: 5.1 Regulation In U.S.:; 5.2 Regulation In Canada:; 5.3 Regulation In Spain:; 5.4 Regulation In U.K.:; 5.5 Regulation In India
6 Market Overview: 6.1 Drivers; 6.1.1 Growing Prevalence Of Cold Sore Infection; 6.1.2 Growing Awareness About Cold Sore Symptoms And Treatment Options; 6.1.3 Impact Of Generic Drugs On The North America Cold Sore Treatment (For Hsv 1 Virus) Market; 6.2 Restraints; 6.2.1 Development Of Drug-resistant Strains Of Hsv-1 And H11 Viruses; 6.2.2 Lack Of Curative Treatment For Infection; 6.3 Opportunities; 6.3.1 Rising Advancements In Treatments For Cold Sore Infections; 6.3.2 Increasing Adoption Of Telemedicine And Digital Health Solutions; 6.4 Challenges; 6.4.1 Increasing Complexity Of Vaccine Development; 6.4.2 Side Effects Associated With Medications In Treating Cold Sore
7 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type: 7.1 Overview; 7.2 Medications; 7.2.1 Antiviral Agents; 7.2.2 Analgesic Agents; 7.2.3 Others; 7.3 Applied Products; 7.3.1 Branded; 7.3.2 Generics; 7.4 Cold Sore Patches; 7.4.1 Semi Occlusive Hydrocolloid Patch; 7.4.2 Film Forming Patch; 7.5 Others (Non Medicated Products)
8 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration: 8.1 Overview; 8.2 Oral; 8.2.1 Tablets; 8.2.2 Capsules; 8.2.3 Others; 8.3 Topical; 8.3.1 Cream; 8.3.2 Lip Balm; 8.3.3 Others; 8.4 Others
9 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Mode Of Purchase: 9.1 Overview; 9.2 Over The Counter; 9.3 Prescription Drug
10 North America Cold Sore Treatment (For Hsv1 Virus) Market, By Strain Type: 10.1 Overview; 10.2 Herpes Simplex Type 1 Virus; 10.3 Herpes Simplex Type 2 Virus
11 North America Cold Sore Treatment (For Hsv1 Virus) Market, By Drug Type: 11.1 Overview; 11.2 Generic; 11.3 Branded
12 North America Cold Sore Treatment (For Hsv1 Virus) Market, By Population Type: 12.1 Overview; 12.2 Adults; 12.3 Pediatrics; 12.4 Geriatrics
13 North America Cold Sore Treatment (For Hsv1 Virus) Market, By Gender: 13.1 Overview; 13.2 Female; 13.3 Male
14 North America Cold Sore Treatment (For Hsv1 Virus) Market, By End User: 14.1 Overview; 14.2 Home Healthcare; 14.3 Hospitals; 14.4 Specialty Clinics; 14.5 Others
15 North America Cold Sore Treatment (For Hsv1 Virus) Market, By Distribution Channel: 15.1 Overview; 15.2 Direct Tenders; 15.3 Retail Sales
16 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Region: 16.1 North America; 16.1.1 U.S.; 16.1.2 Canada; 16.1.3 Mexico
17 North America Cold Sore Treatment (For Hsv 1 Virus) Market: Company Landscape: 17.1 Company Share Analysis: North America
18 Swot Analysis
19 Company Profile: 19.1 Fresenius Se & Co. Kgaa; 19.1.1 Company Snapshot; 19.1.2 Revenue Analysis; 19.1.3 Company Share Analysis; 19.1.4 Product Portfolio; 19.1.5 Recent Development; 19.2 Zydus Pharmaceuticals Inc.; 19.2.1 Company Snapshot; 19.2.2 Company Share Analysis; 19.2.3 Product Portfolio; 19.2.4 Recent Development; 19.3 Teva Pharmaceutical Industries Ltd.; 19.3.1 Company Snapshot; 19.3.2 Revenue Analysis; 19.3.3 Company Share Analysis; 19.3.4 Product Portfolio; 19.3.5 Recent Development; 19.4 Novartis Ag; 19.4.1 Company Snapshot; 19.4.2 Revenue Analysis; 19.4.3 Company Share Analysis; 19.4.4 Product Portfolio; 19.4.5 Recent Development; 19.5 Sun Pharmaceuticals Industries Limited; 19.5.1 Company Snapshot; 19.5.2 Revenue Analysis; 19.5.3 Company Share Analysis; 19.5.4 Product Portfolio; 19.5.5 Recent Development; 19.6 Amneal Pharmaceuticals Llc; 19.6.1 Company Snapshot; 19.6.2 Revenue Analysis; 19.6.3 Product Portfolio; 19.6.4 Recent Development; 19.7 Amparo Medical Technologies; 19.7.1 Company Snapshot; 19.7.2 Product Portfolio; 19.7.3 Recent Development; 19.8 Apotex Inc.; 19.8.1 Company Snapshot; 19.8.2 Product Portfolio; 19.8.3 Recent Development; 19.9 Blistex Inc.; 19.9.1 Company Snapshot; 19.9.2 Product Portfolio; 19.9.3 Recent Development; 19.10 Carma Labs Inc.; 19.10.1 Company Snapshot; 19.10.2 Product Portfolio; 19.10.3 Recent Development; 19.11 Church & Dwight Co., Inc.; 19.11.1 Company Snapshot; 19.11.2 Revenue Analysis; 19.11.3 Product Portfolio; 19.11.4 Recent Development; 19.12 Devirex Ag; 19.12.1 Company Snapshot; 19.12.2 Product Portfolio; 19.12.3 Recent Development; 19.13 Focus Consumer Healthcare; 19.13.1 Company Snapshot; 19.13.2 Product Portfolio; 19.13.3 Recent Development; 19.14 Gsk Plc.; 19.14.1 Company Snapshot; 19.14.2 Revenue Analysis; 19.14.3 Product Portfolio; 19.14.4 Recent Development; 19.15 Haleon Group Of Companies; 19.15.1 Company Snapshot; 19.15.2 Revenue Analysis; 19.15.3 Product Portfolio; 19.15.4 Recent Development; 19.16 Hetero Health Care Limited; 19.16.1 Company Snapshot; 19.16.2 Product Portfolio; 19.16.3 Recent Development; 19.17 Hikma Pharmaceuticals Plc; 19.17.1 Company Snapshot; 19.17.2 Revenue Analysis; 19.17.3 Product Portfolio; 19.17.4 Recent Development; 19.18 Quantum Health; 19.18.1 Company Snapshot; 19.18.2 Product Portfolio; 19.18.3 Recent Development; 19.19 Urgo Medical; 19.19.1 Company Snapshot; 19.19.2 Product Portfolio; 19.19.3 Recent Development; 19.20 Viatris Inc.; 19.20.1 Company Snapshot; 19.20.2 Revenue Analysis; 19.20.3 Product Portfolio; 19.20.4 Recent Development
20 Questionnaire
21 Related Reports
List of Tables: Table 1 Figures; Table 1 Treatment Of Pediatric Hsv Infections; Table 2 Treatment Options; Table 3 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 4 North America Medications In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031 (Usd Thousand); Table 5 North America Medications In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 6 North America Antiviral Agents In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 7 North America Analgesic Agents In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 8 North America Applied Products In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031 (Usd Thousand); Table 9 North America Applied Products In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Table 10 North America Branded In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Table 11 North America Applied Products In Cold Sore Treatment (For Hsv 1 Virus) Market, By Category, 2022-2031 (Usd Thousand); Table 12 North America Cold Sore Patches In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031 (Usd Thousand); Table 13 North America Cold Sore Patches In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 14 North America Others (Non Medicated Products) In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031 (Usd Thousand); Table 15 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 16 North America Oral In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031 (Usd Thousand); Table 17 North America Oral In Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 18 North America Topical In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031 (Usd Thousand); Table 19 North America Topical In Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 20 North America Others In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031 (Usd Thousand); Table 21 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Mode Of Purchase, 2022-2031 (Usd Thousand); Table 22 North America Over The Counter In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031 (Usd Thousand); Table 23 North America Prescription In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031 (Usd Thousand); Table 24 North America Cold Sore Treatment (For Hsv1 Virus) Market, By Strain Type, 2022- 2031 (Usd Thousand); Table 25 North America Herpes Simplex Type 1 Virus In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 26 North America Herpes Simplex Type 2 Virus In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 27 North America Cold Sore Treatment (For Hsv1 Virus) Market, By Drug Type, 2022- 2031 (Usd Thousand); Table 28 North America Generic In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 29 North America Branded In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 30 North America Branded In Cold Sore Treatment (For Hsv 1 Virus) Market, By Drug Type, 2022-2031; Table 31 North America Cold Sore Treatment (For Hsv1 Virus) Market, By Population Type, 2022- 2031 (Usd Thousand); Table 32 North America Adults In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 33 North America Pediatrics In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 34 North America Geriatrics In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 35 North America Cold Sore Treatment (For Hsv1 Virus) Market, By Gender, 2022- 2031 (Usd Thousand); Table 36 North America Female In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 37 North America Male In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 38 North America Cold Sore Treatment (For Hsv1 Virus) Market, By End User, 2022- 2031 (Usd Thousand); Table 39 North America Home Healthcare In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 40 North America Hospitals In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 41 North America Specialty Clinics In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 42 North America Others In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 43 North America Cold Sore Treatment (For Hsv1 Virus) Market, By Distribution Channel, 2022- 2031 (Usd Thousand); Table 44 North America Direct Tenders In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 45 North America Retail Sales In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 46 North America Retail Sales In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031; Table 47 North America Others In Cold Sore Treatment (For Hsv 1 Virus) Market, By Region, 2022-2031; Table 48 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Country, 2022-2031 (Usd Thousand); Table 49 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 50 North America Medications In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 51 North America Antiviral Agents In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 52 North America Analgesic Agents In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 53 North America Applied Products In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Table 54 North America Branded In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Table 55 North America Applied Products In Cold Sore Treatment (For Hsv 1 Virus) Market, By Category, 2022-2031 (Usd Thousand); Table 56 North America Cold Sore Patches In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 57 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 58 North America Oral In Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 59 North America Topical In Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 60 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Mode Of Purchase, 2022-2031 (Usd Thousand); Table 61 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Strain Type, 2022-2031 (Usd Thousand); Table 62 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Drug Type, 2022-2031 (Usd Thousand); Table 63 North America Branded In Cold Sore Treatment (For Hsv 1 Virus) Market, By Drug Type, 2022-2031 (Usd Thousand); Table 64 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Population Type, 2022-2031 (Usd Thousand); Table 65 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Gender, 2022-2031 (Usd Thousand); Table 66 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By End User, 2022-2031 (Usd Thousand); Table 67 North America Cold Sore Treatment (For Hsv 1 Virus) Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 68 North America Retail Sales In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Table 69 U.S. Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 70 U.S. Medications In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 71 U.S. Antiviral Agents In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 72 U.S. Analgesic Agents In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 73 U.S. Applied Products In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Table 74 U.S. Branded In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Table 75 U.S. Applied Products In Cold Sore Treatment (For Hsv 1 Virus) Market, By Category, 2022-2031 (Usd Thousand); Table 76 U.S. Cold Sore Patches In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 77 U.S. Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 78 U.S. Oral In Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 79 U.S. Topical In Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 80 U.S. Cold Sore Treatment (For Hsv 1 Virus) Market, By Mode Of Purchase, 2022-2031 (Usd Thousand); Table 81 U.S. Cold Sore Treatment (For Hsv 1 Virus) Market, By Strain Type, 2022-2031 (Usd Thousand); Table 82 U.S. Cold Sore Treatment (For Hsv 1 Virus) Market, By Drug Type, 2022-2031 (Usd Thousand); Table 83 U.S. Branded In Cold Sore Treatment (For Hsv 1 Virus) Market, By Drug Type, 2022-2031 (Usd Thousand); Table 84 U.S. Cold Sore Treatment (For Hsv 1 Virus) Market, By Population Type, 2022-2031 (Usd Thousand); Table 85 U.S. Cold Sore Treatment (For Hsv 1 Virus) Market, By Gender, 2022-2031 (Usd Thousand); Table 86 U.S. Cold Sore Treatment (For Hsv 1 Virus) Market, By End User, 2022-2031 (Usd Thousand); Table 87 U.S. Cold Sore Treatment (For Hsv 1 Virus) Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 88 U.S. Retail Sales In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Table 89 Canada Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 90 Canada Medications In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 91 Canada Antiviral Agents In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 92 Canada Analgesic Agents In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 93 Canada Applied Products In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Table 94 Canada Branded In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Table 95 Canada Applied Products In Cold Sore Treatment (For Hsv 1 Virus) Market, By Category, 2022-2031 (Usd Thousand); Table 96 Canada Cold Sore Patches In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 97 Canada Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 98 Canada Oral In Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 99 Canada Topical In Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 100 Canada Cold Sore Treatment (For Hsv 1 Virus) Market, By Mode Of Purchase, 2022-2031 (Usd Thousand); Table 101 Canada Cold Sore Treatment (For Hsv 1 Virus) Market, By Strain Type, 2022-2031 (Usd Thousand); Table 102 Canada Cold Sore Treatment (For Hsv 1 Virus) Market, By Drug Type, 2022-2031 (Usd Thousand); Table 103 Canada Branded In Cold Sore Treatment (For Hsv 1 Virus) Market, By Drug Type, 2022-2031 (Usd Thousand); Table 104 Canada Cold Sore Treatment (For Hsv 1 Virus) Market, By Population Type, 2022-2031 (Usd Thousand); Table 105 Canada Cold Sore Treatment (For Hsv 1 Virus) Market, By Gender, 2022-2031 (Usd Thousand); Table 106 Canada Cold Sore Treatment (For Hsv 1 Virus) Market, By End User, 2022-2031 (Usd Thousand); Table 107 Canada Cold Sore Treatment (For Hsv 1 Virus) Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 108 Canada Retail Sales In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Table 109 Mexico Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 110 Mexico Medications In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 111 Mexico Antiviral Agents In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 112 Mexico Analgesic Agents In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 113 Mexico Applied Products In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Table 114 Mexico Branded In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Table 115 Mexico Applied Products In Cold Sore Treatment (For Hsv 1 Virus) Market, By Category, 2022-2031 (Usd Thousand); Table 116 Mexico Cold Sore Patches In Cold Sore Treatment (For Hsv 1 Virus) Market, By Treatment Type, 2022-2031 (Usd Thousand); Table 117 Mexico Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 118 Mexico Oral In Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 119 Mexico Topical In Cold Sore Treatment (For Hsv 1 Virus) Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 120 Mexico Cold Sore Treatment (For Hsv 1 Virus) Market, By Mode Of Purchase, 2022-2031 (Usd Thousand); Table 121 Mexico Cold Sore Treatment (For Hsv 1 Virus) Market, By Strain Type, 2022-2031 (Usd Thousand); Table 122 Mexico Cold Sore Treatment (For Hsv 1 Virus) Market, By Drug Type, 2022-2031 (Usd Thousand); Table 123 Mexico Branded In Cold Sore Treatment (For Hsv 1 Virus) Market, By Drug Type, 2022-2031 (Usd Thousand); Table 124 Mexico Cold Sore Treatment (For Hsv 1 Virus) Market, By Population Type, 2022-2031 (Usd Thousand); Table 125 Mexico Cold Sore Treatment (For Hsv 1 Virus) Market, By Gender, 2022-2031 (Usd Thousand); Table 126 Mexico Cold Sore Treatment (For Hsv 1 Virus) Market, By End User, 2022-2031 (Usd Thousand); Table 127 Mexico Cold Sore Treatment (For Hsv 1 Virus) Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 128 Mexico Retail Sales In Cold Sore Treatment (For Hsv 1 Virus) Market, By Type, 2022-2031 (Usd Thousand); Figure 1 North America Cold Sore Treatment (For Hsv 1 Virus) Market: Segmentation; Figure 2 North America Cold Sore Treatment (For Hsv 1 Virus) Market: Data Triangulation; Figure 3 North America Cold Sore Treatment (For Hsv 1 Virus) Market: Droc Analysis; Figure 4 North America Cold Sore Treatment (For Hsv 1 Virus) Market: North America Vs Regional Market Analysis; Figure 5 North America Cold Sore Treatment (For Hsv 1 Virus) Market: Company Research Analysis; Figure 6 North America Cold Sore Treatment (For Hsv 1 Virus) Market: Interview Demographics; Figure 7 North America Cold Sore Treatment (For Hsv 1 Virus) Market: Market Application Coverage Grid; Figure 8 North America Cold Sore Treatment (For Hsv 1 Virus) Market: Dbmr Market Position Grid; Figure 9 North America Cold Sore Treatment (For Hsv 1 Virus) Market: Vendor Share Analysis; Figure 10 North America Cold Sore Treatment (For Hsv 1 Virus) Market: Segmentation; Figure 11 Growing Prevalence Of Cold Sore Infection Is Driving The Growth Of The North America Cold Sore Treatment (For Hsv 1 Virus) Market From 2024 To 2031; Figure 12 The Treatment Type Segment Is Expected To Account For The Largest Share Of The North America Cold Sore Treatment (For Hsv 1 Virus) Market In 2024 And 2031; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of North America Cold Sore Treatment (For Hsv 1 Virus) Market; Figure 14 North America Cold Sore Treatment (For Hsv 1 Virus) Market : By Treatment Type, 2023; Figure 15 North America Cold Sore Treatment (For Hsv 1 Virus) Market : By Treatment Type, 2024-2031 (Usd Thousand); Figure 16 North America Cold Sore Treatment (For Hsv 1 Virus) Market : By Treatment Type, Cagr (2024-2031); Figure 17 North America Cold Sore Treatment (For Hsv 1 Virus) Market : By Treatment Type, Lifeline Curve; Figure 18 North America Cold Sore Treatment (For Hsv 1 Virus) Market : By Route Of Administration, 2023; Figure 19 North America Cold Sore Treatment (For Hsv 1 Virus) Market : By Route Of Administration, 2024-2031 (Usd Thousand); Figure 20 North America Cold Sore Treatment (For Hsv 1 Virus) Market : By Route Of Administration, Cagr (2024-2031); Figure 21 North America Cold Sore Treatment (For Hsv 1 Virus) Market : By Route Of Administration, Lifeline Curve; Figure 22 North America Cold Sore Treatment (For Hsv 1 Virus) Market : By Mode Of Purchase, 2023; Figure 23 North America Cold Sore Treatment (For Hsv 1 Virus) Market : By Mode Of Purchase, 2024-2031 (Usd Thousand); Figure 24 North America Cold Sore Treatment (For Hsv 1 Virus) Market : By Mode Of Purchase, Cagr (2024-2031); Figure 25 North America Cold Sore Treatment (For Hsv 1 Virus) Market : By Mode Of Purchase, Lifeline Curve; Figure 26 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Strain Type, 2023; Figure 27 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Strain Type, 2024-2031 (Usd Thousand); Figure 28 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Strain Type, Cagr (2024-2031); Figure 29 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Strain Type, Lifeline Curve; Figure 30 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Drug Type, 2023; Figure 31 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Drug Type, 2024-2031 (Usd Thousand); Figure 32 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Drug Type, Cagr (2024-2031); Figure 33 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Drug Type, Lifeline Curve; Figure 34 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Population Type, 2023; Figure 35 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Population Type, 2024-2031 (Usd Thousand); Figure 36 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Population Type, Cagr (2024-2031); Figure 37 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Population Type, Lifeline Curve; Figure 38 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Gender, 2023; Figure 39 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Gender, 2024-2031 (Usd Thousand); Figure 40 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Gender, Cagr (2024-2031); Figure 41 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Gender, Lifeline Curve; Figure 42 North America Cold Sore Treatment (For Hsv1 Virus) Market: By End User, 2023; Figure 43 North America Cold Sore Treatment (For Hsv1 Virus) Market: By End User, 2024-2031 (Usd Thousand); Figure 44 North America Cold Sore Treatment (For Hsv1 Virus) Market: By End User, Cagr (2024-2031); Figure 45 North America Cold Sore Treatment (For Hsv1 Virus) Market: By End User, Lifeline Curve; Figure 46 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Distribution Channel, 2023; Figure 47 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Distribution Channel, 2024-2031 (Usd Thousand); Figure 48 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Distribution Channel, Cagr (2024-2031); Figure 49 North America Cold Sore Treatment (For Hsv1 Virus) Market: By Distribution Channel, Lifeline Curve; Figure 50 North America Cold Sore Treatment (For Hsv 1 Virus) Market: Snapshot (2023); Figure 51 North America Cold Sore Treatment (For Hsv 1 Virus) Market: Company Share 2023 (%)

Pricing

Currency Rates

Single User Email from Publisher $3,500
Global Site License Email from Publisher $4,200

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now